Eliran Mor, MD is the California Center for Reproductive Health’s Medical Director. He is a Reproductive Endocrinologist best known for his patient-centric approach to reproductive and fertility care, focusing on the patient and their ability to make the best decisions when it comes to their fertility and their health. Dr. Mor is considered a highly valued physician at the California Center for Reproductive Health and has created a practice that supports and promotes a healthy and holistic approach to reproductive endocrinology and fertility.
Dr. Mor received his medical degree from the University of Tel Aviv-Sackler School of Medicine in Israel and completed a 4-year residency in Obstetrics and Gynecology at New York Methodist Hospital in Brooklyn, New York. He became a board-certified doctor in California in 2001 and is also a member of the American Board of Obstetrics and Gynecology in the areas of obstetrics and gynecology, and reproductive endocrinology, and infertility. Dr. Mor subsequently completed a three-year fellowship in Reproductive Endocrinology and Infertility at the University of Southern California.
He is also a member in excellent standing with a variety of other prestigious medical organizations including the American Society of Reproductive Medicine (ASRM), the Pacific Coast Reproductive Society (PCRS), the Society of Laparoendoscopic Surgeons (SLS), and the American College of Obstetricians and Gynecologists (ACOG), and remains a Clinical Instructor at USC.
Throughout his career, Dr. Mor has focused his time and talents on researching the latest treatments and advancements in reproductive health. He has been published more than a dozen times in notable, peer-reviewed medical journals, such as the Journal of Assisted Reproduction and Genetics; Fertility and Sterility; and the American Journal of Obstetrics and Gynecology. His articles have focused on many different topics related to reproductive health, with titles such as “Spontaneous twin gestation after vaginal dilation in a woman with uterus didelphys and bladder exstrophy,” and “Serum androgen levels in controlled ovarian hyperstimulation cycles utilizing gonadotropin-releasing hormone antagonists or agonists.”
His published work has been supplemented by abstracts he has co-presented at different medical conferences and events. As part of his commitment to learning the newest treatments and the latest information in the field, Dr. Mor endeavors to attend at least two medical conferences per year. He has co-presented at meetings such as the 50th Annual Meeting of the Society for Gynecologic Investigation, March 2003, in Washington, DC. Abstract topics covered have included “Defective autophosphorylation of the insulin receptor (APIR): A potential mechanism of insulin resistance in polycystic ovary syndrome (PCOS),” and “Effects of soy and a very low-fat diet on serum insulin and leptin levels in healthy postmenopausal women: A prospective randomized trial.”
All of these research papers and abstracts focus on Eliran Mor, MD’s specific interests in the area of infertility and human reproduction, including polycystic ovary syndrome (PCOS); emergency contraception; neuroendocrinology; insulin resistance; male factor infertility; donor sperm insemination; tubal factor infertility; IVF stimulation protocols; congenital uterine anomalies; tubal gamete/embryo transfer (GIFT/ZIFT/TET); pregnancy at advanced reproductive age; and hormone replacement therapy (HRT).
As a member of the medical staff at the California Center for Reproductive Health, Dr. Mor has been recognized for his commitment to creating a LGBTQIA-friendly and transgender safe space. He is dedicated to helping individuals and families on their journey through infertility and works to provide the most relevant and helpful information to his patients so that they are able to make the right choice for themselves and their care. He is a valued member of the CCRH team, and Dr. Eliran Mor looks forward to working with patients as they begin on the road to starting or expanding their families.
Advertising disclosure: We may receive compensation for some of the links in our stories. Thank you for supporting LA Weekly and our advertisers.